Pfizer buys Anacor for $5.2bn

18-05-2016

Pfizer buys Anacor for $5.2bn

StockStudio / Shutterstock.com

Pfizer has announced that it will be buying Anacor Pharmaceuticals for $5.2 billion, which will lead to it adding an experimental treatment for eczema, called Crisaborole, to its portfolio.


Pfizer, Anacor Pharmaceuticals, crisaborole, shares, mergers and acquisitions

More on this story

Actavis and Pfizer settle Celebrex litigation
29-04-2014

LSIPR